Source: Brazilian journal of psychiatry. Unidade: FM
Subjects: ANTIDEPRESSIVOS, DEPRESSÃO, MÉTODO DUPLO-CEGO, POLIMORFISMO, OXIGENASE, TERAPIA COMBINADA, TRANSFERASES, AMINAS (COMPOSTOS ORGÂNICOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRUNONI, Andre Russowsky et al. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial. Brazilian journal of psychiatry, v. 42, n. 2, p. 128-135, 2020Tradução . . Disponível em: https://doi.org/10.1590/1516-4446-2019-0620. Acesso em: 26 ago. 2024.APA
Brunoni, A. R., Carracedo, A., Amigo, O. M., Pellicer, A. L., Talib, L., Carvalho, A. F., et al. (2020). Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial. Brazilian journal of psychiatry, 42( 2), 128-135. doi:10.1590/1516-4446-2019-0620NLM
Brunoni AR, Carracedo A, Amigo OM, Pellicer AL, Talib L, Carvalho AF, Lotufo PA, Benseñor IJM, Gattaz WF, Cappi C. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial [Internet]. Brazilian journal of psychiatry. 2020 ; 42( 2): 128-135.[citado 2024 ago. 26 ] Available from: https://doi.org/10.1590/1516-4446-2019-0620Vancouver
Brunoni AR, Carracedo A, Amigo OM, Pellicer AL, Talib L, Carvalho AF, Lotufo PA, Benseñor IJM, Gattaz WF, Cappi C. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial [Internet]. Brazilian journal of psychiatry. 2020 ; 42( 2): 128-135.[citado 2024 ago. 26 ] Available from: https://doi.org/10.1590/1516-4446-2019-0620